Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Dermatologic Oncology

Epacadostat plus pembrolizumab in patients with advanced solid tumors: Phase I results from a multicenter, open-label phase I/II trial (ECHO-202/KEYNOTE-037)

Journal of Clinical Oncology | Nov 19, 2018 Dermatologic Oncology

Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness

Journal of the American Academy of Dermatology | Nov 19, 2018 Dermatologic Oncology

Longer follow-up confirms relapse-free survival benefit with adjuvant dabrafenib plus trametinib in patients with resected BRAF V600–mutant stage III melanoma

Journal of Clinical Oncology | Nov 18, 2018 Dermatologic Oncology

The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis

Gynecologic Oncology | Nov 14, 2018 Dermatologic Oncology

Modeled prognostic subgroups for survival and treatment outcomes in BRAF V600–mutated metastatic melanoma: Pooled analysis of 4 randomized clinical trials

JAMA | Nov 07, 2018 Dermatologic Oncology

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients With BRAF-mutated melanoma and other advanced malignancies

Cancer | Nov 07, 2018 Dermatologic Oncology

Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma

International Journal of Cancer | Nov 04, 2018 Dermatologic Oncology

Oral contraceptive use and cutaneous melanoma risk: A French prospective cohort study

International Journal of Cancer | Nov 02, 2018 Dermatologic Oncology

Survival after the diagnosis of de novo malignancy in liver transplant recipients

International Journal of Cancer | Nov 01, 2018 Dermatologic Oncology

Phase Ib/II study of pembrolizumab and pegylated-interferon alfa-2b in advanced melanoma

Journal of Clinical Oncology | Oct 31, 2018 Dermatologic Oncology

« Prev 1 … 38 39 40 41 42 … 57 Next »

Epacadostat plus pembrolizumab in patients with advanced solid tumors: Phase I results from a multicenter, open-label phase I/II trial (ECHO-202/KEYNOTE-037)

Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness

Longer follow-up confirms relapse-free survival benefit with adjuvant dabrafenib plus trametinib in patients with resected BRAF V600–mutant stage III melanoma

The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis

Modeled prognostic subgroups for survival and treatment outcomes in BRAF V600–mutated metastatic melanoma: Pooled analysis of 4 randomized clinical trials

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients With BRAF-mutated melanoma and other advanced malignancies

Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma

Oral contraceptive use and cutaneous melanoma risk: A French prospective cohort study

Survival after the diagnosis of de novo malignancy in liver transplant recipients

Phase Ib/II study of pembrolizumab and pegylated-interferon alfa-2b in advanced melanoma

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Epacadostat plus pembrolizumab in patients with advanced solid tumors: Phase I results from a multicenter, open-label phase I/II trial (ECHO-202/KEYNOTE-037)

Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness

Longer follow-up confirms relapse-free survival benefit with adjuvant dabrafenib plus trametinib in patients with resected BRAF V600–mutant stage III melanoma

The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis

Modeled prognostic subgroups for survival and treatment outcomes in BRAF V600–mutated metastatic melanoma: Pooled analysis of 4 randomized clinical trials

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients With BRAF-mutated melanoma and other advanced malignancies

Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma

Oral contraceptive use and cutaneous melanoma risk: A French prospective cohort study

Survival after the diagnosis of de novo malignancy in liver transplant recipients

Phase Ib/II study of pembrolizumab and pegylated-interferon alfa-2b in advanced melanoma

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic